Suppressing fatty acid synthase by type I interferon and chemical inhibitors as a broad spectrum anti-viral strategy against SARS-CoV-2
Saba R. Aliyari(University of California, Los Angeles), Genhong Cheng(University of California, Los Angeles), Karen Reue(University of California, Los Angeles), Olivier Pernet(University of California, Los Angeles), Ann-Jay Tong(University of California, Los Angeles), Stephen T. Smale(Howard Hughes Medical Institute), Armin Takallou(University of California, Los Angeles), Clay F. Semenkovich(Washington University in St. Louis), Xiaochao Wei(Washington University in St. Louis), Benhur Lee(Icahn School of Medicine at Mount Sinai), Hoda Gerami(University of California, Los Angeles), Laurent Vergnes(University of California, Los Angeles), Adel Zhang(University of California, Los Angeles), Yao Wang(Kunming University of Science and Technology), Amir A. Ghaffari(University of California, Los Angeles), Linda Chilin(George Mason University), Yuntao Wu(George Mason University)
Cited by 34
Related Papers
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|943
Multifunctional Mesoporous Composite Microspheres with Well-Designed Nanostructure: A Highly Integrated Catalyst System
|Journal of the American Chemical Society|2010|920